2019 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
2009 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2019 | 0 | 8.391.240 | 310.138 | 1 | ||
2010 | 0 | 11.996.730 | 100.000 | 1 |
Total number of partners: 44
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 44
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2019-06-01 | Vaccine for prevention and treatment of Trypanosoma cruzi infection | CRUZIVAX | participant | 8.391.240 | 11 |
2010-01-01 | Discovery and preclinical development of new generation tuberculosis vaccines | NEWTBVAC | participant | 11.996.730 | 35 |